Effects of calcium channel blockers on renal function in mice
- 1 January 1992
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 22 (3) , 443-446
- https://doi.org/10.1016/0360-3016(92)90849-d
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Bioreductive drugs and the selective induction of tumour hypoxiaBritish Journal of Cancer, 1990
- Effects of the manipulation of oxyhemoglobin status by BW121 on tumor thermosensitivity and on blood flow in tumor and normal tissues in miceInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Enhancement of the anti-tumor effect of melphalan in experimental mice by some vaso-active agentsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Cinnarizine and flunarizine as radiation sensitisers in two murine tumoursBritish Journal of Cancer, 1988
- Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazineBritish Journal of Cancer, 1988
- Cardiovascular and Renal Actions of Calcium Channel Blocker Chemical Subgroups: a Search for Renal SpecificityJournal of Pharmacy and Pharmacology, 1988
- Chemical modification of tumour blood flowInternational Journal of Hyperthermia, 1988
- The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gainInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Verapamil potentiation of melphalan cytotoxicity and cellular uptake in murine fibrosarcoma and bone marrowBritish Journal of Cancer, 1985